【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 10
1.1 List of Tables 17
1.2 List of Figures 23
2 Introduction 26
2.1 Catalyst 26
2.2 Related Reports 27
2.3 Upcoming Related Reports 27
3 Disease Overview 28
3.1 Etiology and Pathophysiology 28
3.1.1 Etiology 28
3.1.2 Pathophysiology 28
3.1.3 Melanoma Biomarkers 29
3.2 Clinical Staging 30
3.3 Symptoms 32
3.4 Prognosis 32
3.5 Quality of Life 34
4 Epidemiology 35
4.1 Disease Background 35
4.2 Risk Factors and Comorbidities 35
4.3 Global Trends 38
4.3.1 US 39
4.3.2 5EU 39
4.3.3 Japan and Australia 39
4.4 Forecast Methodology 40
4.4.1 Sources Used 42
4.4.2 Sources Not Used 49
4.4.3 Forecast Assumptions and Methods 49
4.5 Epidemiological Forecast for Melanoma (2013-2023) 52
4.5.1 Diagnosed Incident Cases of Melanoma 52
4.5.2 Age-Specific Diagnosed Incident Cases of Melanoma 54
4.5.3 Sex-Specific Diagnosed Incident Cases of Melanoma Skin Cancer 56
4.5.4 Age-Standardized Diagnosed Incidence Rates 58
4.5.5 Pathological Stage at Diagnosis 60
4.5.6 Five-Year Diagnosed Prevalent Cases of Melanoma Skin Cancer 61
4.5.7 Five-Year Diagnosed Prevalent Cases of Melanoma Skin Cancer by Genetic Aberrations 63
4.6 Discussion 65
4.6.1 Epidemiological Forecast Insight 65
4.6.2 Limitations of the Analysis 66
4.6.3 Strengths of the Analysis 67
5 Disease Management 68
5.1 Diagnosis Overview 68
5.2 Treatment Overview 69
5.2.1 Localized Melanoma: Stage 0 to Stage IIC 71
5.2.2 Regional Melanoma: Stage IIIA to Stage IIIC 72
5.2.3 Unresectable and Metastatic Melanoma: Stage III and Stage IV 75
5.3 US 81
5.3.1 Screening and Diagnosis 82
5.3.2 Clinical Practices 84
5.4 France 86
5.4.1 Screening and Diagnosis 87
5.4.2 Clinical Practices 87
5.5 Germany 88
5.5.1 Screening and Diagnosis 89
5.5.2 Clinical Practices 90
5.6 Italy 93
5.6.1 Screening and Diagnosis 94
5.6.2 Clinical Practices 94
5.7 Spain 96
5.7.1 Screening and Diagnosis 97
5.7.2 Clinical Practices 97
5.8 UK 98
5.8.1 Screening and Diagnosis 99
5.8.2 Clinical Practices 99
5.9 Japan 101
5.9.1 Screening and Diagnosis 101
5.9.2 Clinical Practices 102
5.10 Australia 103
5.10.1 Screening and Diagnosis 104
5.10.2 Clinical Practices 105
6 Competitive Assessment 108
6.1 Overview 108
6.2 Interferon-based Adjuvant Therapies 110
6.2.1 Roferon-A (Interferon Alfa-2a) 110
6.2.2 Intron A (Interferon Alfa-2b) 114
6.2.3 Sylatron (Peginterferon Alfa-2b) 118
6.3 Immune Checkpoint Inhibitors 124
6.3.1 Yervoy (Ipilimumab) 124
6.3.2 Opdivo (Nivolumab) 134
6.3.3 Keytruda (Pembrolizumab) 143
6.4 BRAF Mutation-targeted Therapies 151
6.4.1 Zelboraf (Vemurafenib) 151
6.4.2 Tafinlar (Dabrafenib) 158
6.4.3 Mekinist (Trametinib) 164
6.5 Other Therapeutic Classes 176
7 Unmet Need and Opportunity 178
7.1 Overview 178
7.2 Therapeutic Options for BRAF Wild-Type Patients 180
7.2.1 Unmet Need 180
7.2.2 Gap Analysis 181
7.2.3 Opportunity 182
7.3 Therapies for Non-responders to PD-1 Immunotherapy 183
7.3.1 Unmet Need 183
7.3.2 Gap Analysis 184
7.3.3 Opportunity 186
7.4 Adjuvant Therapies for High-Risk Resectable Melanoma 188
7.4.1 Unmet Need 188
7.4.2 Gap Analysis 189
7.4.3 Opportunity 191
7.5 Effective Treatment for Brain Metastases 193
7.5.1 Unmet Need 193
7.5.2 Gap Analysis 194
7.5.3 Opportunity 196
7.6 Predictive Markers for Therapeutic Response to Immunotherapies 197
7.6.1 Unmet Need 197
7.6.2 Gap Analysis 198
7.6.3 Opportunity 200
8 Pipeline Assessment 201
8.1 Overview 201
8.2 Promising Drugs in Clinical Development 202
8.3 RAF/RAS/MEK Pathway-Targeting Therapies 204
8.3.1 Cobimetinib (GDC-0973) 204
8.3.2 Encorafenib (LGX818) 211
8.3.3 Binimetinib (MEK162) 217
8.4 Immune-Related Therapies 224
8.4.1 Talimogene Laherparepvec 224
8.4.2 Eltrapuldencel-T (NSB20) 232
8.4.3 Seviprotimut-L (POL-103A) 238
8.4.4 PV-10 244
8.5 Promising Drugs in Early-Stage Development 250
8.5.1 PI3K/Akt/mTOR Pathway-Targeting Therapies 250
8.5.2 Cell Cycle Checkpoint Inhibitors 252
8.5.3 Next-Generation BRAF Inhibitors 254
8.5.4 Immunotherapies 256
8.5.5 Antibody-Drug Conjugates 259
8.6 Other Drugs in Development 261
9 Current and Future Players 263
9.1 Overview 263
9.2 Trends in Corporate Strategy 266
9.3 Company Profiles 267
9.3.1 Bristol-Myers Squibb 267
9.3.2 Novartis 270
9.3.3 Roche 273
9.3.4 Merck 276
10 Market Outlook 280
10.1 Global Markets 280
10.1.1 Forecast 280
10.1.2 Drivers and Barriers — Global Issues 284
10.2 United States 286
10.2.1 Forecast 286
10.2.2 Key Events 290
10.2.3 Drivers and Barriers — US 291
10.3 5EU 293
10.3.1 Forecast 293
10.3.2 Key Events 297
10.3.3 Drivers and Barriers — France 298
10.3.4 Drivers and Barriers — Germany 300
10.3.5 Drivers and Barriers — Italy 301
10.3.6 Drivers and Barriers — Spain 303
10.3.7 Drivers and Barriers — UK 304
10.4 Japan 306
10.4.1 Forecast 306
10.4.2 Key Events 309
10.4.3 Drivers and Barriers — Japan 309
10.5 Australia 311
10.5.1 Forecast 311
10.5.2 Key Events 314
10.5.3 Drivers and Barriers — Australia 315
11 Appendix 317
11.1 Bibliography 317
11.2 Abbreviations 344
11.3 Methodology 349
11.4 Forecasting Methodology 349
11.4.1 Diagnosed Melanoma Patients 349
11.4.2 Percent Drug-Treated Patients 350
11.4.3 Drugs Included in Each Therapeutic Class 350
11.4.4 Launch and Patent Expiry Dates 351
11.4.5 General Pricing Assumptions 352
11.4.6 Average Body Weight and Surface Area Across the 8MM 353
11.4.7 Individual Drug Assumptions 354
11.4.8 Generic Erosion 368
11.4.9 Pricing of Pipeline Agents 368
11.5 Primary Research – KOLs Interviewed for this Report 370
11.6 Primary Research – Prescriber Survey 373
11.7 About the Authors 374
11.7.1 Analyst 374
11.7.2 Therapy Area Director 374
11.7.3 Epidemiologist 375
11.7.4 Global Head of Healthcare 375
11.8 About GlobalData 376
11.9 Disclaimer 376
【レポート販売概要】
■ タイトル：黒色腫治療薬の世界市場予測および分析■ 英文：PharmaPoint: Melanoma - Global Drug Forecast and Market Analysis to 2023
■ 発行日：2015年4月5日
■ 調査会社：GlobalData
■ 商品コード：GDHC104PIDR
■ 調査対象地域：グローバル
- 防汚塗料の世界市場分析：用途別（輸送船、掘削リグ･生産プラットフォーム）、セグメント予測 – 2022The global Antifouling Coating Market is expected to reach USD 2.43 billion by 2022, according to a new report by Grand View Research, Inc. Antifouling coatings are applied in order to increase the durability of hulls and underwater surfaces of marine vessels including passenger ships, cargoes, yachts and drilling rigs. Increasing number of merchant fleets on account of improvement of ship-based l …
- 医療用エクソスケルトンの世界市場予測（～2023年）The global medical exoskeleton market is projected to reach USD 571.6 million by 2023 from USD 116.7 million in 2018, at a CAGR of 37.4% during the forecast period. Factors such as the increasing number of people with physical disabilities and subsequent growth in the demand for effective rehabilitation approaches and increasing insurance coverage for medical exoskeletons in several countries are …
- ジオシンセティックスの世界市場：ジオテキスタイル、ジオメンブレン、ジオグリッド、ジオフォーム、ジオネットThe Geosynthetics market size in terms of value is projected to grow at a CAGR of 10.99% between 2014 and 2019 to reach $15,403.7 million by 2019. North America held the largest share in 2013, in terms of value. The Geosynthetics market in North America region is growing fast, mainly due to evolving environmental regulations and standards, for example, The Environmental Protection Agency (EPA) in …
- Dimethyl Succinateの世界市場Dimethyl Succinate(DMS) (CAS 106-65-0) Market Research Report 2013 presents comprehensive data on dimethyl succinate(dms) markets globally and regionally (Europe, Asia, North America etc.) The report includes dimethyl succinate(dms) description, covers its application areas and related patterns. It overviews dimethyl succinate(dms) market, names dimethyl succinate(dms) producers and indicates its …
- OTCブレース及びサポートの世界市場予測（～2024年）“The OTC braces and supports market is projected to grow at a CAGR of 5.1% during the forecast period” The OTC braces and supports market is projected to reach USD 1.5 billion by 2024 from USD 1.2 billion in 2019, at a CAGR of 5.1%. The growth in this market is majorly driven by the increasing prevalence of orthopedic diseases & disorders, rising number of sports and accident-related injuries, and …
- スマートソーラーの世界市場：ネットワーク監視、メーターデータ管理、アナリティクス、SCADA、リモート計量、資産管理、停電管理MarketsandMarkets forecast the smart solar market size to grow from USD 6.47 Billion in 2015 to USD 13.26 Billion by 2020, at a compound annual growth rate (CAGR) of 15.4%. Strict mandates of regulatory bodies has led the organizations to upgrade to the upcoming technological solutions, such as analytics and real-time monitoring. This acts as a primary driving factor for the smart solar market as …
- 世界のサイバーセキュリティー（Cybersecurity）市場動向2013-2023：トレンド、開発動向及び課題Technological Developments in the global Cybersecurity include: Network based IP sensor to enable detection of cyber attacks Machine Learning technology to be the new platform for future cyber security measures Development of offensive cyber weapons on the rise Middle East emerging as one of the major markets Cyber security domain recording robust M&A activity Lack of exhaustive databases on malwa …
- コネクテッドカーの世界市場予測（～2022年）“Regularity mandates on some connected car modules and vehicle data updates for defect detection, which would help the manufacturer to recall vehicles in time is expected to drive the growth of the connected car market” The connected car market is expected to grow from 5.1 million units in 2015 to 37.7 million units by 2022, at a CAGR of 35.54% during the forecast period. Regularity mandates on so …
- Thermo Fisher Scientific, Inc.：市場シェア分析Thermo Fisher Scientific, Inc. Market Share Analysis Summary GlobalData’s new report, “Thermo Fisher Scientific, Inc. Market Share Analysis” provides in-depth information on Thermo Fisher Scientific, Inc.’s market position in the different medical equipment markets it operates in. The report provides Thermo Fisher Scientific, Inc. market share information in five key market categories – Infectious …
- 世界のVoice over Mobile Broadband (VoMBB)市場動向（2012-2016）Global Voice over Mobile Broadband (VoMBB) Market 2012-2016 Voice over Mobile Broadband, or VoMBB, has been recently gaining traction in the Global Telecom industry and is unanimously expected to generate huge revenue for telecom network operators in the coming years. Conceptually, VoMBB is about encompassing carrier-grade voice calls over LTE, Wi-Fi and HSPA/HSPA+ networks. While Wi-Fi is a nifty …
- 世界主要国の無煙たばこ市場Summary “Smokeless Tobacco Key Markets” is the result of ERC’s extensive market research covering the smokeless tobacco market of twenty major countries which include Belgium, Canada, Czech Republic, Finland, France, Hungary, India, Japan, Netherlands, South Africa, Switzerland, Denmark, Germany, Italy, Norway, Poland, Spain, Sweden, the UK and the USA. It provides an analysis of changing consumpt …
- エンタプライズLBS（位置情報システム）の世界市場2016-2020About Enterprise LBS Market Location-based services (LBS) track the location of users within a wireless network using location-enabled mobile devices. User-initiated LBS requires an Internet connection to obtain a user's location and provide search results. Location-enabled mobile devices include smartphones, tablets, personal navigation devices (PND), and certain in-dash devices fitted in vehicle …
- インスリン抵抗性（Insulin Resistance）：グローバル臨床試験レビュー（2014年上半期）Insulin Resistance Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Insulin Resistance Global Clinical Trials Review, H1, 2014" provides data on the Insulin Resistance clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Insulin Resistance. It includes an overview of the trial numbers and their recruitme …
- スマート農業の世界市場予測（～2023年）：精密農業、家畜モニタリング、養殖、スマートグリーンハウスThe smart agriculture market is estimated to be worth USD 7.53 billion in 2018 and is projected to reach USD 13.50 billion by 2023, at a CAGR of 12.39% between 2018 and 2023. Major factors contributing to the growth of the smart agriculture market include the increasing adoption of advanced technologies in various agriculture applications such as precision farming, smart green house, livestock mon …
- PeruのAsbestos市場：貿易（輸入、輸出）動向This market research report examines the foreign trade of Peru and its perspectives on the global market for asbestos. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on asbestos export/import operations in Peru. The 2002-2011 period is covered, with more emphasis on for …
